Relation between body mass index, waist circumference, and death after acute myocardial infarction

Circulation

Volumn 118, Issue 5, 2008, Pages 482-490

  Zeller, Marianne ^a,f   Steg, Philippe Gabriel ^b   Ravisy, Jack ^c   Lorgis, Luc ^d   Laurent, Yves ^e   Sicard, Pierre ^a   Janin Manificat, Luc ^e   Beer, Jean Claude ^d   Makki, Hamid ^e   Lagrost, Anne Cécile ^d   Rochette, Luc ^a   Cottin, Yves ^d  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b INSERM   (France)

^c Clinique de Fontaine   (France)

^d HÔPITAL DU BOCAGE   (France)

^e CENTRE HOSPITALIER   (France)

^f IFR Sante STIC   (France)

Author keywords

Body mass index; Death; Myocardial infarction; Obesity

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; COHORT ANALYSIS; FOLLOW UP; HEART INFARCTION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; RISK FACTOR; WAIST HIP RATIO;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; PREDICTIVE VALUE OF TESTS; RISK FACTORS; WAIST-HIP RATIO;

EID: 49649103588     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.753483     Document Type: Article

References (34)

1. Barrett-Connor EL. Obesity, atherosclerosis, and coronary artery disease. Ann Intern Med. 1985;103:1010-1019.
2. Wolk R, Berger P, Lennon RJ, Brilakis ES, Somers VK. Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation. 2003;108:2206-2211.
3. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Sauer LF, Lindsay J Jr. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39:578-584.
4. Gurm HS, Whitlow PL, Kip KE. The impact of body mass index on short-and long-term outcomes inpatients undergoing coronary revascularization: insights from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 2002;39:834-840.
5. Buettner HJ, Mueller C, Gick M, Ferenc M, Allgeier J, Comberg T, Werner KD, Schindler C, Neumann FJ. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J. 2007;28:1694-1701.
6. Mehta L, Devlin W, McCullough PA, O'Neill WW, Skelding KA, Stone GW, Boura JA, Grines CL. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol. 2007;99:906-910.
7. Diercks DB, Roe MT, Mulgund J, Pollack CV Jr, Kirk JD, Gibier WB, Ohman EM, Smith SC Jr, Boden WE, Peterson ED. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J. 2006;152:140-148.
8. Poirier P. Adiposity and cardiovascular disease: are we using the right definition of obesity? Eur Heart J. 2007;28:2047-2048.
9. Romero-Corral A, Somers VK, Sierra-Johnson J, Jensen MD, Thomas RJ, Squires RW, Allison TG, Korinek J, Lopez-Jimenez F. Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J. 2007;28:2087-2093.
10. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881-887.
11. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460-468.
12. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54:254-260.
13. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk, Int J Obes Relat Metab Disord. 2004;28:1018-1025.
14. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manifrcat L, L'Huillier I, Beer JC, Oudot A, Rioufol G, Makki H, Farnier M, Rochelte L, Verges B, Cottin Y. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med. 2005;165: 1192-1198.
15. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959-969.
16. World Health Organization. Obesity: Preventing and managing the global epidemic. Report on a WHO Consultation. Geneva, Switzerland: World Health Organization; 2000.
17. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
18. Wang Y, Rimm EB, Stampfer MJ, Willen WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81:555-563.
19. Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS, Murphy JG, Jaffe AS. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol. 2006;110:153-159.
20. Eisenstein EL, McGuire DK, Bhapkar MV, Kristinsson A, Hochman JS, Kong DF, Califf RM, Van de Werf F, Yancy WS Jr, Newby LK. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes. Am J Med. 2005;118:981-990.
21. Nikolsky E, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Negoita M, Lansky AJ, Mehran R. Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J. 2006;151:168-175.
22. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594-600.
23. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM. Canham RM, Chung AK, Leonard D, Wians FH Jr, de Lemos JA. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation. 2005;112: 2163-2168.
24. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, MeCabe CH, Hall C, Cannon CP, Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014-1021.
25. Jernberg T, Lindahl B, Siegbahn A, Andren B, Frostfeldt G, Lagerqvist B, Stridsberg M, Venge P, Wallentin L. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol. 2003;42:1909-1916.
26. Lindahl B, Lindbäck J, Jernberg T, Johnston N, Stridsberg M, Venge P, Wallentin L. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and Fast Revascularisation During Instability in Coronary Artery Disease (FRISC)-II substudy. J Am Coll Cardiol. 2005;45:533-541.
27. McCord J, Mundy BJ, Hudson MP, Maisel AS, Hollander JE, Abraham WT, Steg PG, Omland T, Knudsen CW, Sandberg KR, McCuUough PA. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med. 2004;164:2247-2252.
28. Williams SR, Jones E, Bell W, Davies B, Bourne MW. Body habitus and coronary heart disease in men: a review with reference to methods of body habitus assessment. Eur Heart J. 1997;18:376-393.
29. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
30. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J. 2002;23:706-713.
31. Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J. 2005;149:54-60.
32. See R, Abdullah SM, McGuire DK, Khera A, Patel MJ, Lindsey JB, Grundy SM, de Lemos JA. The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study. J Am Coll Cardiol. 2007;50:752-759.
33. Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S. Buchan I, Day N, Khaw KT. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation. 2007;116:2933-2943.
34. Minutello RM, Chou ET, Hong MK, Bergman G, Parikh M, Iacovone F, Wong SC. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry). Am J Cardiol. 2004;93:1229-1232.